Lv1
20 积分 2025-02-17 加入
Treatment-naïve Gaucher disease patients achieve therapeutic goals and normalization with velaglucerase alfa by 4years in phase 3 trials
22天前
已完结
Reductions in glucosylsphingosine (lyso-Gb1) in treatment-naïve and previously treated patients receiving velaglucerase alfa for type 1 Gaucher disease: Data from phase 3 clinical trials
22天前
已完结
Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial
4个月前
已完结
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
4个月前
已完结
Long-term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-center, Open-label, Phase IIIb Study
4个月前
已完结
Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial
4个月前
已完结
Pharmacokinetics and Pharmacodynamics of Mepolizumab, an Anti-Interleukin-5 Monoclonal Antibody
4个月前
已完结
Pharmacokinetics, pharmacodynamics and clinical efficacy of omalizumab for the treatment of asthma
4个月前
已完结
WHO WINS THE WAR AGAINST DIABETES? COMPARATIVE EFFICACY OF TIRZEPATIDE, SEMAGLUTIDE, AND PLACEBO IN DIABETES CONTROL: A NETWORK META-ANALYSIS
1年前
已关闭
Long-Term Clinical and Economic Effects of Switching to Once-Weekly Semaglutide from Other GLP-1 RAs Among Patients with Type 2 Diabetes in China: A Modeling Projection Study
1年前
已完结
皖公网安备34019202002308
